Health News
New Birth Control Pill
June 29, 2006
The Food and Drug Administration is holding off on approving a new oral contraceptive drug called Lybrel. Wyeth, the company who created the contraceptive, hopes to offer Lybrel to women as an alternative to traditional oral contraceptives.
Lybrel had been designed to eliminate women's monthly periods. Traditional oral contraceptives require women to take placebo pills for one week in the monthly cycle which causes a menstruation period. Lybrel could be a preferred alternative for some women who could avoid the monthly bloating, cramps and bleeding associated with having a period.
The FDA is looking to receive additional data on the contraceptive and where is it manufactured before they approve the drug.